This compound is primarily used in the synthesis of pharmaceutical intermediates, particularly in the development of chiral molecules. Its structure, featuring a tert-butoxycarbonyl (Boc) protecting group and a phenyl moiety, makes it valuable in peptide synthesis and the production of enantiomerically pure compounds. It is often employed in the preparation of active pharmaceutical ingredients (APIs) for drugs targeting neurological and cardiovascular disorders. Additionally, its chiral center allows for the creation of stereospecific compounds, which are crucial in drug design to ensure efficacy and reduce side effects. It is also utilized in research for developing new therapeutic agents and studying biochemical pathways.